Literature DB >> 25351863

A nationwide register-based survey of baclofen toxicity.

Louise Bendix Kiel1, Lotte Christine Groth Hoegberg, Tejs Jansen, John Asger Petersen, Kim Peder Dalhoff.   

Abstract

To study the use and misuse (poisonings) of baclofen in the time period of 2007-2012 and to evaluate the severity and clinical symptoms of poisonings including ingested baclofen. The National Patient Register (NPR) was searched for admissions due to baclofen poisonings from 2007 to 2012. The search was conducted with ICD-10 codes for poisoning, self-harm and suicide, and coupled with the baclofen ATC code. All enquiries about baclofen to the Danish Poison Information Centre (DPIC) in the same period were evaluated. Demographic and clinical data were extracted, and the poisonings were classified according to the Poison Severity Score. The number of baclofen poisonings did not increase from 2007 to 2012. Thirty-eight admissions with baclofen poisoning were registered at the NPR; however, only one-third of the reviewed DPIC cases were registered at the NPR with the correct coding. In the group of severely poisoned patients (PSS 3), three patients had only ingested baclofen (mean 2000 mg; SD 500 mg) and eight patients had ingested baclofen together with alcohol or psychotropic drugs (mean 900 mg; SD 641 mg). All patients presented with deep coma and respiratory depression. Additionally, seizures and cardiovascular events (mild hypo- or hypertension and bradycardia) occurred. There is a substantial degree of underreporting of baclofen poisonings in Denmark. Symptoms of baclofen poisoning progress very fast, and toxicity was observed even with doses as low as 150 mg. We therefore recommend that observation and treatment of these patients should be carried out in an intermediate- or intensive care unit. The most important treatment is the maintenance of a protected airway and respiration.
© 2014 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25351863     DOI: 10.1111/bcpt.12344

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  12 in total

1.  Efficacy and side effects of baclofen and the novel GABAB receptor positive allosteric modulator CMPPE in animal models for alcohol and cocaine addiction.

Authors:  Valentina Vengeliene; Tatiane T Takahashi; Olga A Dravolina; Irina Belozertseva; Edwin Zvartau; Anton Y Bespalov; Rainer Spanagel
Journal:  Psychopharmacology (Berl)       Date:  2018-04-12       Impact factor: 4.530

2.  Polysomnographic Analysis of a Pediatric Case of Baclofen-Induced Central Sleep Apnea.

Authors:  Federica Locatelli; Francesca Formica; Sara Galbiati; Paolo Avantaggiato; Elena Beretta; Carla Carnovale; Marco Pozzi; Emilio Clementi; Sandra Strazzer
Journal:  J Clin Sleep Med       Date:  2019-02-15       Impact factor: 4.062

Review 3.  Progress in Developing Pharmacologic Agents to Treat Bulimia Nervosa.

Authors:  Susan L McElroy; Anna I Guerdjikova; Nicole Mori; Francisco Romo-Nava
Journal:  CNS Drugs       Date:  2019-01       Impact factor: 5.749

4.  Transient alteration of consciousness in spinal cord injury secondary to Baclofen use: a case report.

Authors:  Thomas John Pisano; Jessica Ace; Beverly Hon
Journal:  Spinal Cord Ser Cases       Date:  2022-05-21

5.  The Poisoning Severity Score: If It Did Not Exist, We Would Have To Invent It.

Authors:  Rose Cairns; Nicholas A Buckley
Journal:  J Med Toxicol       Date:  2017-05-17

6.  Encephalopathy and hypotonia due to baclofen toxicity in a patient with end-stage renal disease.

Authors:  Mohsin Ijaz; Hassan Tariq; Muhammad Kashif; Jose Gomez Marquez
Journal:  Am J Case Rep       Date:  2015-04-20

Review 7.  How to Manage Self-Poisoning With Baclofen in Alcohol Use Disorder? Current Updates.

Authors:  Nicolas Franchitto; Benjamin Rolland; Fanny Pelissier; Nicolas Simon
Journal:  Front Psychiatry       Date:  2018-09-04       Impact factor: 4.157

Review 8.  Baclofen therapeutics, toxicity, and withdrawal: A narrative review.

Authors:  Jia W Romito; Emily R Turner; John A Rosener; Landon Coldiron; Ashutosh Udipi; Linsey Nohrn; Jacob Tausiani; Bryan T Romito
Journal:  SAGE Open Med       Date:  2021-06-03

9.  Treatment of motor and behavioural symptoms in three Lesch-Nyhan patients with intrathecal baclofen.

Authors:  Marco Pozzi; Luigi Piccinini; Maurizio Gallo; Francesco Motta; Sonia Radice; Emilio Clementi
Journal:  Orphanet J Rare Dis       Date:  2014-12-12       Impact factor: 4.123

Review 10.  Safety Challenges of Using High Dose Baclofen for Alcohol Use Disorder: A Focused Review.

Authors:  Benjamin Rolland; Nicolas Simon; Nicolas Franchitto
Journal:  Front Psychiatry       Date:  2018-08-22       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.